Oral and Maxillofacial Surgery

, Volume 14, Issue 3, pp 133–142 | Cite as

Management of oral submucous fibrosis: an overview

Review Article

Abstract

Oral submucous fibrosis is a disease due to a chronic, insidious change in fibroelasticity, characterized by burning sensation in the oral cavity, blanching, and stiffening of the oral mucosa and oro-pharynx leading to trismus and inability to open the mouth. The symptoms and signs depend on the progression of the lesions and number of affected sites. It is predominantly seen in Indians and other Asians. Once, the disease has developed, there is neither regression nor any effective treatment. It is considered as a pre-malignant stage of oral cancer and reported risk of malignant transformation varies from 2.3-7.6%.The common etiological factor considered for this unremitting disease is use of areca nut; however, the precise pathogenesis still remains elusive and controversial. A wide range of treatment consisting of drug management, surgical therapy, and physiotherapy have been attempted till date; with varying degrees of benefit, but none of them have proved to be a cure for this disease. This field remains open for clinical trials and research. This paper aims to provide an overview on various management modalities available for oral submucous fibrosis.

Keywords

Oral submucous fibrosis Areca nut Conservative management Surgical management 

References

  1. 1.
    Pindborg JJ, Sirasat SM (1966) Oral submucous fibrosis. Oral surg Oral Med Oral Pathol 22:746–779CrossRefGoogle Scholar
  2. 2.
    Canniff JP, Harvey W, Harris M (1986) Oral submucous fibrosis: its pathogenesis and management. Br Dent J 160:429–434PubMedCrossRefGoogle Scholar
  3. 3.
    Laskaris G, Bovopoulou O, Nicolis G (1981) Oral submucous fibrosis in a greek female. Br J Oral Surg 19:197–201PubMedCrossRefGoogle Scholar
  4. 4.
    Paissat DK (1981) Oral submucous fibrosis. Int J Oral Surg 10:307–312PubMedCrossRefGoogle Scholar
  5. 5.
    Sinor PN, Gupta PC, Murti PR (1990) A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19:94–98PubMedCrossRefGoogle Scholar
  6. 6.
    Joshi SG (1953) Submucous fibrosis of the palate and pillars. Indian J Otolaryngol 4:1–4Google Scholar
  7. 7.
    Sirasat SM, Pindborg JJ (1967) Subepithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 70:161–173CrossRefGoogle Scholar
  8. 8.
    Canniff JP, Harvey W (1981) The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 10:163–167PubMedGoogle Scholar
  9. 9.
    van Wyk CW, Seedat HA, Phillips VM (1990) Collagen in submucous fibrosis: an electron microscopic study. J Oral Pathol Med 19:182–187PubMedCrossRefGoogle Scholar
  10. 10.
    Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS (1984) Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 89:270–274Google Scholar
  11. 11.
    Kwan HW (1976) A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing—a preliminary report. J Formos Med assoc 75:497–505Google Scholar
  12. 12.
    Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS (1997) Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 25:377–383CrossRefGoogle Scholar
  13. 13.
    Mani NJ, Singh B (1976) Studies on oral submucous fibrosis-epithelial changes. Oral Surg 41:203–214PubMedCrossRefGoogle Scholar
  14. 14.
    Jeng JH, Chang MC, Hahn LJ (2001) Role of areca nut in betel quid associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37:477–492PubMedCrossRefGoogle Scholar
  15. 15.
    Pindborg JJ, Mehta FS, Gupta PC, Daftary DK (1968) Prevalence of oral submucous fibrosis among 50,915 Indian villagers. Br J Cancer 22:646–654PubMedGoogle Scholar
  16. 16.
    Rajalalitha P, Vali S (2005) Molecular pathogenesis of oral submucous fibrosis—a collagen metabolic disorder. J Oral Pathol Med 34:321–328PubMedCrossRefGoogle Scholar
  17. 17.
    Cox SC, Walker DM (1996) Oral submucous fibrosis: a review. Aust Dent J 41:294–299PubMedCrossRefGoogle Scholar
  18. 18.
    Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC (1998) Oral submucous fibrosis in India: a new epidemic. Natl Med J 11:113–114Google Scholar
  19. 19.
    Hayes PA (1985) Oral submucous fibrosis in a 4-year-old girl. Oral Surg Oral Med Oral Pathol 59:475–478PubMedCrossRefGoogle Scholar
  20. 20.
    Oliver AJ, Radden BG (1992) Oral submucous fibrosis. Case report and review of literature. Aust Dent J 37:31–34PubMedCrossRefGoogle Scholar
  21. 21.
    Hamner JE, Looney PD, Chused TM (1974) Submucous fibrosis. Oral Surg 37:412–421PubMedCrossRefGoogle Scholar
  22. 22.
    Bhonsle RB, Murti PR, Daftary DK, Gupta PC, Mehta FS, Sinor PN, Irani RR, Pindborg JJ (1987) Regional variations in oral submucous fibrosis in India. Comm Dent Oral Epidemiol 15:225–229CrossRefGoogle Scholar
  23. 23.
    Schwartz J (1962) Atrophica idiopathioca (Tropica) Mucosae oris. In: Proceedings of the 11th International Dental Congress, London, 1992 (Cited by Sirasat and Khanolkar. Indian J Med 16:185–197)Google Scholar
  24. 24.
    Paymaster JC (1956) Cancer of the buccal mucosa: clinical study of 650 cases in Indian patients. Cancer 9:431–435PubMedCrossRefGoogle Scholar
  25. 25.
    Hardie J (1987) Oral submucous fibrosis: a review with case reports. J Can Dent Assoc 53:389–393PubMedGoogle Scholar
  26. 26.
    Pindborg JJ (1972) Is submucous fibrosis a precancerous condition in the oral cavity? Int Dent 22:474–480Google Scholar
  27. 27.
    Pindborg JJ, Chawla TN, Srivastara AN, Gupta PD et al (1972) Clinical aspects of oral submucous fibrosis. Acta Odontol Scand 22:679–691CrossRefGoogle Scholar
  28. 28.
    Shiau YY, Kwan HW (1979) Submucous fibrosis in Taiwan. Oral Surg 47:454–457CrossRefGoogle Scholar
  29. 29.
    Morawetz G, Katsikeris N, Weinberg S, Listorm R (1987) Oral submucous fibrosis. Int J Oral Maxillofac Surg 16:609–714PubMedCrossRefGoogle Scholar
  30. 30.
    Pillai R, Balaram P (1992) Pathogenesis of oral submucous fibrosis, relationship to risk factors associated with cancer. Cancer 69:2011–2020PubMedCrossRefGoogle Scholar
  31. 31.
    Warnakulasuriya KAAS, Trivedy C, Maher R, Johnson NW (1997) Aetiology of oral submucous fibrosis. Oral Dis 3:286–287Google Scholar
  32. 32.
    Sinor PN, Gupta PC, Murti PR et al (1990) A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19:94–98PubMedCrossRefGoogle Scholar
  33. 33.
    Seedat H, Van Wyk CW (1988) Submucous fibrosis in non betel nut chewing subjects. J Biol Buccale 16:3–6PubMedGoogle Scholar
  34. 34.
    Seedat HA, Van Wyk CW (1998) Betel nut chewing and submucous fibrosis in Durban. S Afr Med J 74:568–571Google Scholar
  35. 35.
    Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS (1995) Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 24:145–152PubMedCrossRefGoogle Scholar
  36. 36.
    Shah N, Sharma PP (1998) Role of chewing and smoking habits in the etiology of oral submucous fibrosis—a case control study. J Oral Pathol Med 27:475–479PubMedCrossRefGoogle Scholar
  37. 37.
    Yang YH, Lien YC, Ho PS, Chen CH, Chang JSF, Cheng TC, Shieh TY (2005) The effects of chewing arca/betel quid with and without cigarette smoking on oral submucous fibrosis and oral mucosal lesions. Oral Dis 11:88–94PubMedCrossRefGoogle Scholar
  38. 38.
    Yusuf H, Yong SL (2002) Oral submucous fibrosis in a 12-year-old Bangaladeshi boy: a case report and review of literature. Int J Pediatr Dent 12:271–276CrossRefGoogle Scholar
  39. 39.
    Ranganathan K, Uma Devi M, Elizabeth J, Kiran Kumar K, Saraswathi TR (2004) Oral submucous fibrosis: a case—control study in Chennai, South India. J Oral Pathol Med 33:274–277PubMedCrossRefGoogle Scholar
  40. 40.
    Merchant AT, Haider SM, Fikree FF (1997) Increased severity of oral submucous fibrosis in young Pakistani men. Br J Oral Maxillofac Surg 35:284–287PubMedCrossRefGoogle Scholar
  41. 41.
    Tilakaratne WM, Klinikowski MF, Takashi S, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on etiology and pathogenesis. Oral Oncol 42:561–568PubMedCrossRefGoogle Scholar
  42. 42.
    Rajendran R (1994) Oral submucous fibrosis:etiology, pathogenesis, and future research. Bull World Health Org 72:985–996PubMedGoogle Scholar
  43. 43.
    Murti PR, Gupta PC, Bhonsle RB, Daftary DK, Mehta FS, Pindborg JJ (1990) Effect on the incidence of oral submucous fibrosis of intervention in the areca nut chewing habit. J Oral Pathol Med 19:99–100PubMedCrossRefGoogle Scholar
  44. 44.
    Maher R, Lee AJ, Warnakulasuriya KAAS, Lewis JA, Johnson NW (1994) Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 23:65–69PubMedCrossRefGoogle Scholar
  45. 45.
    Reichart PA, Van Wyk CW, Becker J, Schuppan D (1994) Distribution of procollagen typeIII, collagen typeIV and tenascin in oral submucous fibrosis. J Oral Pathol Med 23:394–398PubMedCrossRefGoogle Scholar
  46. 46.
    Harvey W, Scutt A, Meghji S, Canniff P (1986) Stimulation of human buccal mucosa fibroblast in vitro by betel nut alkaloids. Arch Oral Biol 31:45–49PubMedCrossRefGoogle Scholar
  47. 47.
    Kuo MYP, Chen HM, Hahn LJ, Hsieh CC, Chaian CP (1995) Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74:1783–1788PubMedCrossRefGoogle Scholar
  48. 48.
    De Waal J, Olivier A, Van Wyk CW, Maritz JS (1997) The fibroblast population in oral submucous fibrosis. J Oral Pathol Med 26:69–74PubMedCrossRefGoogle Scholar
  49. 49.
    Meghji S, Scutt A, Harvey W, Canniff JP (1987) An invitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol 32:213–215PubMedCrossRefGoogle Scholar
  50. 50.
    Haue MF, Meghji S, Khitab U, Harris M (2000) Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29:123–128CrossRefGoogle Scholar
  51. 51.
    Kundendu AB, Radhakrishnan R, Satyamoorthy K (2008) The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 37:402–411CrossRefGoogle Scholar
  52. 52.
    Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC (2005) Raised keratinocyte growth factor-1 expression in oral submucous in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 34:100–105PubMedCrossRefGoogle Scholar
  53. 53.
    Haue MF, Harris M, Meghji S, Spieght PM (1997) An immunohistochemical study of oral submucous fibrosis. J Oral Pathol Med 26:75–82CrossRefGoogle Scholar
  54. 54.
    Tsai CH, Yang SF, Chen YJ, My C, Chang YC (2005) The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol 41:940–946PubMedCrossRefGoogle Scholar
  55. 55.
    Haue MF, Harris M, Meghji S, Barret AW (1998) Immunolocalisation of cytokines and growth factors in oral submucous fibrosis. Cytokine 10:713–719CrossRefGoogle Scholar
  56. 56.
    Tsai CH, Chou MY, Chang YC (2003) The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32:146–153PubMedCrossRefGoogle Scholar
  57. 57.
    Chang YC, Tai KW, Cheng MH, Chou LSS, Chou MY (1998) Cytotoxic and nongenotoxic effects of arecoline on human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 27:68–71PubMedCrossRefGoogle Scholar
  58. 58.
    Chui CJ, Chang ML, Chaing CP, Hahn LJ, Hsieh LL, Chaen CJ (2002) Interaction of collagen-related genes and susceptibility to betel quid induced oral submucous fibrosis. Cancer Epidemiol Biomark Prev 11:646–653Google Scholar
  59. 59.
    Chiu CJ, Cp C, Chang ML (2001) Association between genetic polymorphism of tumor necrosis factor alpha and risk of oral submucous fibrosis, a precancerous condition of oral cancer. J Dent Res 80:2055–2059PubMedCrossRefGoogle Scholar
  60. 60.
    Lui CJ, Lee YJ, Chang KW, Sinh YN, Liu HF, Dang CW (2004) Polymorphism of the MICA gene and risk for oral submucous fibrosis. J Oral Pathol Med 33:1–6CrossRefGoogle Scholar
  61. 61.
    Shin YN, Lui CJ, Chang KW, Lee YY, Lui HF (2004) Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan. J Oral Pathol Med 33:1–6CrossRefGoogle Scholar
  62. 62.
    Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP, Liu TY (2006) The functional (−1171 5A → 6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. J Oral Pathol Med 35:99–103PubMedCrossRefGoogle Scholar
  63. 63.
    Utsunomiya H, Tilakaratne WM, OshiroK MS, Suzuki M, Ida-Yonemochi H, Cheng J, Saku T (2005) Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 34:498–507PubMedCrossRefGoogle Scholar
  64. 64.
    Scutt A, Meghji S, Canniff JP, Harvey W (1987) Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experimentia 43:391–393CrossRefGoogle Scholar
  65. 65.
    Meghji S, Scutt A, Canniff JP, Harvey W, Phillipson JD (1982) Inhibition of collagenase activity by areca nut tannins: a mechanism of collagen accumulation in oral submucous fibrosis. J Dent Res 61:545Google Scholar
  66. 66.
    Shieh TY, Yang JF (1992) Collagenase activity in oral submucous fibrosis. Pro Natl Sci Counc China B 16:106–110Google Scholar
  67. 67.
    Shieh DH, Chiang LC, Shieh TY (2003) Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and saffrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 39:728–735PubMedCrossRefGoogle Scholar
  68. 68.
    Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS (2002) Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38:195–200PubMedCrossRefGoogle Scholar
  69. 69.
    Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC (2003) The upregulation of typeI plaminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39:367–372PubMedCrossRefGoogle Scholar
  70. 70.
    Rajendran R, Vijaykumar T, Vasudevan DM (1989) An alternative pathogenic pathway for oral submucous fibrosis. Med Hypotheses 30:231–239CrossRefGoogle Scholar
  71. 71.
    Tsai CC, Ma RH, Shieh TY (1999) Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 28:59–63PubMedCrossRefGoogle Scholar
  72. 72.
    Shieh DH, Chiang LC, Lee CH, Yang YH, Shieh TY (2004) Effects of arecoline, saffrole and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis. J Oral pathol Med 33:581–587PubMedCrossRefGoogle Scholar
  73. 73.
    Tsai Ch, Yang SF, Chang YC (2007) The upregulation of cystatin C in oral submucous fibrosis. Oral Oncol 43:680–685CrossRefGoogle Scholar
  74. 74.
    Trivedy C, Warnakulasuriya KAAS, Hazarey VK, Tavassoli M, Sommer P, Johnson NW (1999) The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med 28:246–251PubMedCrossRefGoogle Scholar
  75. 75.
    Trivedy CR, Warnakulasuriya KAAS, Peter TJ, Senkus R, Hazarey VK, Johnson NW (2000) Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 29:241–248PubMedCrossRefGoogle Scholar
  76. 76.
    Trivedy CR, Meghji S, Warnakulasuriya KAAS, Johnson NW, Harris M (2001) Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 30:465–470PubMedCrossRefGoogle Scholar
  77. 77.
    Trivedy CR, Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, Johnson NW (2000) Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 29:241–248PubMedCrossRefGoogle Scholar
  78. 78.
    Trivedy C, Baldwin D, Warnakulasuriya S, Johnson NW, Peters T (1997) Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 349:1447PubMedCrossRefGoogle Scholar
  79. 79.
    Ma RH, Tsai CC, Shieh TY (1995) Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med 24:407–412PubMedCrossRefGoogle Scholar
  80. 80.
    Haue MF, Meghji S, Nazir R, Harris M (2001) Interferon gamma may reverse oral submucous fibrosis. J Oral Pathol Med 30:12–21CrossRefGoogle Scholar
  81. 81.
    Chiang CP, Hsieh RP, Chen TH (2002) High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med 31:402–409PubMedCrossRefGoogle Scholar
  82. 82.
    Khanna SS, Karjodkar FR (2006) Circulating immune complexes and trace elements (copper, iron and selenium) as markers in oral precancer and cancer: a randomised, controlled clinical. Head Face Med 2:33PubMedCrossRefGoogle Scholar
  83. 83.
    Ghosh PK, Madhavi R, Guntur M, Ghosh R (1990) Sister chromatid exchanges in patients with oral submucous fibrosis. Cancer Genet Cytogenet 44:197–201PubMedCrossRefGoogle Scholar
  84. 84.
    Chiang CP, Wu HY, Lui BY, Wang JT, Kuo MYP (2002) Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan. Oral Oncol 38:56–63PubMedCrossRefGoogle Scholar
  85. 85.
    Gupta DS, Gupta MK, Oswal RH (1985) Estimation of major immunoglobulin profile in oral submucous fibrosis by radial immunodiffusion. Int J Oral Surg 14:533–537PubMedCrossRefGoogle Scholar
  86. 86.
    Shah N, Kumar R, Shah MK (1994) Immunological studies in oral submucous fibrosis. Indian J Dent Res 5:81–87PubMedGoogle Scholar
  87. 87.
    Canniff JP, Batchelor JR, Dodi IA, Harvey W (1982) HLA typing in oral submucous fibrosis. Tissue Antigens 26:138–142CrossRefGoogle Scholar
  88. 88.
    Saeed B, Haue MF, Meghji S, Harris M (1997) HLA typing in oral submucous fibrosis. J Dent Res 76:1024Google Scholar
  89. 89.
    Chen HM, Hsieh RP, Yang H, Kuo YS, Kuao MYP, Chaing CP (2004) HLA antigens in oral submucous fibrosis. J Oral Pathol Med 33:191–199PubMedCrossRefGoogle Scholar
  90. 90.
    Van Wyk CW, Grobler Rabie AF, Martel RW, Hammond MG (1994) HLA antigens in oral submucous fibrosis. J Oral Pathol Med 23:23–27PubMedCrossRefGoogle Scholar
  91. 91.
    Khanna JN, Andrade NN (1995) Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 24:433–449PubMedCrossRefGoogle Scholar
  92. 92.
    Katharia SK, Singh SP, Kulshrestha VK (1992) The effects of placental extract in management of oral submucous fibrosis. Ind J Pharmacology 24:181–183Google Scholar
  93. 93.
    Jiang X, Jing Hu (2009) Drug treatment of oral submucous fibrosis: a review of the literature. J Oral Maxillofac Surg 67:1510–1515PubMedCrossRefGoogle Scholar
  94. 94.
    Aziz RS (2008) Oral submucous fibrosis: case report and review of diagnosis and treatment. J Oral Maxillofac Surg 66:2386–2389PubMedCrossRefGoogle Scholar
  95. 95.
    Fedorowicz Z, Chan Shih YE, Naseer M, Newton T, Shi L (2009) Interventions for the management of oral submucous fibrosis: a review. Cochrane collaboration 2009Google Scholar
  96. 96.
    Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chaing CP (2001) Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 30:618–625PubMedCrossRefGoogle Scholar
  97. 97.
    Jirge V, Ali SM, Anshumalee N (2009) Levamisole and antioxidants in management of oral submucous fibrosis: a comparative study. J Ind Acad Oral Med Radiol 20:135–139CrossRefGoogle Scholar
  98. 98.
    Rajendran R, Rani V, Shaikh S (2006) Pentoxyfylline therapy: a new adjunct in treatment of oral submucoau fibrosis. Indian J Dent Res 17:190–198PubMedCrossRefGoogle Scholar
  99. 99.
    Lai DR, Chen HR, Lin LM (1995) Clinical evaluation of different treatament methods for oral submucous fibrosis: a 10-year experience with 150 cases. J Oral Pathol Med 24:402–407PubMedCrossRefGoogle Scholar
  100. 100.
    Sharma JK, Gupta AK, Mukhija RD (1987) Clinical experience with use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 16:695PubMedCrossRefGoogle Scholar
  101. 101.
    Li XM, Tang J (1998) Clinical treatment obserevation of tea pigment for oral submucous fibrosis. Hua Xi Kou iang YI Xue Za Zhi 16:50–55Google Scholar
  102. 102.
    Gupta S, Reddy MVR, Harinath BC (2004) Role of oxidative stress and antioxidants in aetiopathogeneisi and management of oral submucous fibrosis. Indian J Clin Biochem 19:138–139CrossRefGoogle Scholar
  103. 103.
    Singh M, Krishnappa R, Bagewadi A (2004) efficacy of oral lycopene in the treatment of oral submucous fibrosis. Oral Oncol 40:591PubMedCrossRefGoogle Scholar
  104. 104.
    Kumar A, Bagewadi A, Keluskar V, Singh M (2007) Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:207–213PubMedCrossRefGoogle Scholar
  105. 105.
    Lin HJ, Lin JC (2007) Treatment of oral submucous fibrous by collagenases: effects on oral opening and eating functions. Oral Dis 13:407–413PubMedCrossRefGoogle Scholar
  106. 106.
    Dai JP, Chen J, Bei YF, Han BX, Wang S (2009) Influence of borneol on primary mice oral fibroblasts: a penetration-enhancer may be used in oral submucous fibrosis. J Oral Pathol Med 38:276–281PubMedCrossRefGoogle Scholar
  107. 107.
    Yen DJC (1982) Surgical treatment of submucous fibrosis. Oral Surg 54:269–272PubMedCrossRefGoogle Scholar
  108. 108.
    Haung IY, Wu C, Shen Y, Yang C, Shieh T, Hsu H (2008) Importance of patient’s cooperation in surgical treatment for oral submucous fibrosis. J Oral Maxillofac Surg 66:699–703CrossRefGoogle Scholar
  109. 109.
    Kavarana NM, Bhatena H (1987) Surgery for severe trismus in submucous fibrosis. Br J Plast Surg 40:407–409PubMedCrossRefGoogle Scholar
  110. 110.
    Mehrotra D, Pradhan R, Gupta S (2009) Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:e1–e10PubMedCrossRefGoogle Scholar
  111. 111.
    Chen CM, Yang CF, Shen YS, Huang IY, Wu CF (2008) The use of artificial dermis for surgical defects in the treatment of oral premalignant lesions. J Surg Oncol 97:291–293PubMedCrossRefGoogle Scholar
  112. 112.
    Chao CK, Chang LC, Liu SY, Wang JJ (2002) Histologic examination of pedicled buccal fat pad graft in oral submucous fibrosis. J Oral Maxillofac Surg 60:1131–1134PubMedCrossRefGoogle Scholar
  113. 113.
    Lai DR, Chen HR, Huang YL, Tsai CC (1995) Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 24:402–406PubMedCrossRefGoogle Scholar
  114. 114.
    Mokal NJ, Raje RS, Ranade SV, Rajendra Prasad JS, Thatte RL (2005) Release of oral submucous fibrosis and reconstruction using superficial temporal fascia flap and split skin graft—a new technique. Br J Plast Surg 58:1055–1060PubMedCrossRefGoogle Scholar
  115. 115.
    Borle RM, Nimonkar PV, Rajan R (2009) Extended nasolabial flaps in the management of oral submucous fibrosis. Br J Oral Maxillofac Surg 47:382–385PubMedCrossRefGoogle Scholar
  116. 116.
    Tsao CK, Wei FC, Chang YM, Cheng MH, Chaug DC, Kao HK (2009) Reconstruction of the buccal mucosa following release for submucous fibrosis using two radial forearm flaps from asingle donor site. J Plast Recon Aesth Surg (in press)Google Scholar
  117. 117.
    Omura S, Mizuki N, Horimoto R, Kawabe R, Fujita K (1997) A newly developed collage/silicone bilayer membrane as a mucosal substitute: a preliminary report. Br J Oral Maxillofac Surg 35:85–91PubMedCrossRefGoogle Scholar
  118. 118.
    Huang JJ, Wallace C, Lin JY, Tsao CK, Kao HK, Huang WC (2009) Two small flaps from one anterolateral thigh donor site for bilateral buccal mucosa reconstruction after release of submucous fibrosis and/or contracture. J Plast Recon Aesth Surg. (in press)Google Scholar
  119. 119.
    Le PV, Gornitsky M (1996) Oral stent as treatment adjunct for oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:148–150PubMedCrossRefGoogle Scholar
  120. 120.
    Cox S, Zoellner H (2009) Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 38:220–226PubMedCrossRefGoogle Scholar
  121. 121.
    Patil PG, Parkhedkar RD (2009) New graft stabilizing clip as a treatment adjunct for oral submucous fibrosis. J Prosth Dent 102:191–192CrossRefGoogle Scholar
  122. 122.
    Huang IY, Wu CF, Shen YS, Yang CF, Shieh TY, Hsu HJ et al (2008) Importance of patient’s cooperation in surgical treatment of oral submucous fibrosis. J Oral Maxillofac Surg 66:699–703PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.KLE VK institute of Dental Sciences and HospitalBelgaumIndia

Personalised recommendations